The company’s market value peaked in 2021 at nearly $6 billion amid booming interest in DNA testing kits but demand has waned in recent years, hurting firms such as 23andMe and its Blackstone-owned rival AncestryDNA.
Sales of the consumer kits frequently picked up during holiday season, but 23andMe has…








